Angiogenesis is the formation of new blood vessels. This process is crucial for normal growth and development. In healthy adults, angiogenesis does not normally occur except during ovulation, in the placenta and for wound healing. The international scientific community is hard at work, studying the biological process known as angiogenesis, the formation of new blood vessels. Unfortunately, the formation of new blood vessels can also occur in certain pathological situations, complicating certain diseases.
Angiogenesis performs a critical role in the development of cancer.
Solid tumors smaller than 1 to 2 cubic millimeters are not vascularized. The median survival time of patients treated with a dose of 30mL twice a day was 7.1 months, compared to 16.3 months for patients receiving a dose of 120mL twice a day. For a patient with metastatic renal cell carcinoma who does not respond to standard treatments, the expected survival time is approximately 8 months. . This study is the third pivotal clinical trial Aeterna has initiated in cancer this year. Final results of the trial are expected by summer 2002 .